课题基金 / 基金详情

Can we explain the varying pathologic processes of rheumatoid arthritis by CaMKII delta abnormality?

Can we explain the varying pathologic processes of rheumatoid arthritis by CaMKII delta abnormality?
我们能否通过 CaMKII δ 异常来解释类风湿性关节炎的不同病理过程?
批准号:
20591173
负责人:
KAWAKAMI Atsushi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KAWAKAMI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have examined the relationship between the pathogenesis of rheumatoid arthritis (RA) and CaMKII/PADIs/peptide citrullination/cellular abnormality of synovial cells and immune competent cells. Expression of PADIs in the rheumatoid synovial tissues remains to be clarified at present. According to our data, the expression of PADIs was weak whereas that of PADIs substrates were present in rheumatoid synovial cells. PADIs substrates in rheumatoid synovial cells could be citrullinated by interaction with neighboring immune competent cells, resulting in stimulation of anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) in patients with RA. Our present data also suggested that the function of regulatory T cells (Treg cells), a major immune competent cell population, is down-regulated in patients with RA that may associate with perpetuation of the disease's process. However, further investigation is necessary to identify whether these phenomena are primary events or secondary results. In addition, the investigations regarding to the association of Treg cells with CaMKII/PADIs are also be necessary. In clinical study, we have identified a close association of MRI-proven bone edema with anti-CCP antibodies. At present, a detection of peptide citrullination is very difficult. Therefore, we are also going to solve this problem by immune complexsome analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
インフリキシマブの関節リウマチ患者の炎症所見、活動性とADLに対する効果
英夫利昔单抗对类风湿关节炎患者炎症表现、活动和 ADL 的影响
DOI: --
发表时间: 2010
期刊: 日本RAのリハビリ研究会誌 24巻
影响因子: --
作者: [折口智樹, 川尻真也, 岩本直樹, 玉井慎美, 井田弘明, 川上純, 他]
通讯作者:
関節リウマチ滑膜細胞におけるRNA結合蛋白を介したIL-6の転写後制御の可能性
类风湿性关节炎滑膜细胞中通过 RNA 结合蛋白转录后调节 IL-6 的可能性
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [古賀智裕, 山崎聡士, 他]
通讯作者:
【関節リウマチ "治癒をめざす"最新治療コンセンサス】治療戦略治療開始 いつから治療をするか?どの薬剤を開始するか?
【类风湿性关节炎最新治疗共识,以治愈为目标】 治疗策略 开始治疗 什么时候开始治疗?
DOI: --
发表时间: 2010
期刊: 医学のあゆみ
影响因子: --
作者: [玉井慎美, 川上純]
通讯作者: 川上純
TNF阻害薬治療の既往がある関節リウマチに対するトシリズマブ治療の有効性
托珠单抗治疗有 TNF 抑制剂治疗史的类风湿性关节炎的疗效
DOI: --
发表时间: 2010
期刊: 九州リウマチ
影响因子: --
作者: [川尻真也, 岩本直樹, 中村英樹, 折口智樹, 川上純, 江口勝美, 植木幸孝, 右田清志, 溝上明成, 荒牧俊幸]
通讯作者: 荒牧俊幸
86
    Basic research for searching of new therapeutic targets of rheumatoid arthritis through investigation of novel action of CTLA-4-Ig
    • 批准号:
      15K09531
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Investigation of autoantigens in patients with rheumatoid arthritis through protemic analysis: exploration from diagnosis, pathogenesis to therapy
    • 批准号:
      23591439
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Cell and signal mechanisms that support tissue regeneration in fish
    • 批准号:
      21570004
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Investigation for the possibility of CaMKII activity modulation for the therapeutic optical in rheumatoid arthritis
    • 批准号:
      18591116
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    海外基金